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Mash1, a transcription factor of the basic helix±loop±helix class, is expressed during embryogenesis in restricted regions
of the nervous system. An essential role for Mash1 in neural development was demonstrated previously in mice carrying
a targeted disruption of the Mash1 gene. Regulation of the precise temporal and spatial expression of Mash1 is thus likely
to be important for proper neural development. In this study, sequences that regulate Mash1 expression in the central
nervous system were characterized by assaying the expression of lacZ reporter genes in transgenic embryos. A 1158-bp
enhancer localized 7 kb upstream of the Mash1 coding region was identi®ed. Deletions within this enhancer region
reveal the presence of both positive and negative cis-acting elements. Analysis of multiple sequences within the enhancer
demonstrate that different elements preferentially function in different regions within the Mash1-speci®c CNS expression
domain. In addition, a role for sequences 3 * of the Mash1 coding region is revealed, providing evidence for posttranscriptional
control of Mash1 expression in multiple CNS domains. q 1998 Academic Press
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INTRODUCTION tem. Mash1, Math1, neurogenin1/Math4C, and Math4A/
neurogenin2 are expressed in proliferating neuronal progen-
itors (Lo et al., 1991; Guillemot and Joyner, 1993; AkazawaTranscription factors of the basic helix±loop±helix
et al., 1995; Ben-Arie et al., 1996; Gradwohl et al., 1996;(bHLH) family are involved in the development of multiple
Helms and Johnson, 1998). In some regions, Mash1 andcell types including muscle and neuronal lineages in both
Math1 appear to be localized to early differentiating cellsinvertebrates and vertebrates (Kageyama et al., 1995; Yun
since their expression overlaps with both mitotic and post-and Wold, 1996). Expression of members of one subclass
mitotic cells (Porteus et al., 1994; Gordon et al., 1995;within the bHLH family is restricted to early stages of neu-
Helms and Johnson, 1998). In contrast, other members ofral development. This subclass includes the Drosophila
the neural subclass of bHLH factors are expressed at laterproneural genes of the achaete±scute complex and atonal
stages of neuronal differentiation such as NeuroD andthat are required for the development of speci®c neuronal
NSCL1/2 in postmitotic neuronal precursors, and Nex1/sublineages (Campuzano and Modolell, 1992; Jarman et al.,
Math2 in terminally differentiated cells (Begley et al., 1992;1993). Related genes in mammals include Mash1, NeuroD,
Bartholoma and Nave, 1994; Lee et al., 1995; Shimizu etneurogenin1/Math4C, Math4A/neurogenin2, Neurogenin3,
al., 1995; Kawakami et al., 1996; Kume et al., 1996; McCor-Math1, Nex1/Math2, and Math3 (Johnson et al., 1990; Bar-
mick et al., 1996; Yasunami et al., 1996). The role of thesetholoma and Nave, 1994; Akazawa et al., 1995; Lee et al.,
transcription factors in neural development is beginning to1995; Shimizu et al., 1995; Gradwohl et al., 1996; Sommer
be elucidated in overexpression and loss of function studies.et al., 1996; Lemercier et al., 1997; Takebayashi et al., 1997).
These studies suggest that the precise temporal and spatialEach member of this subclass has a distinct pattern of ex-
expression of these bHLH factors is critical for proper devel-pression relative to both the timing of neuronal differentia-
opment of the nervous system (Guillemot et al., 1993; Fer-tion and the domains of expression within the nervous sys-
reiro et al., 1994; Turner and Weintraub, 1994; Ishibashi et
al., 1995; Lee et al., 1995; Ma et al., 1996; Kim et al., 1997).
Mash1 is the best-characterized member of the vertebrate1 To whom correspondence should be addressed. Fax: 214-648-
1801. E-mail: Jane.Johnson@email.swmed.edu. neural-speci®c subclass of bHLH factors. It is expressed
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the untranslated region, an intron, and the polyadenylation signaltransiently in the developing nervous system in spatially
(Fig. 1). For assembly of transgenes 4±10, the restriction enzymeand temporally restricted domains in the central (CNS) and
fragments indicated in Fig. 1 were cloned 5* to transgene 2.peripheral (PNS) nervous systems, olfactory epithelium, and
Heterologous reporter construct hsp68lacZpA (Kothary et al.,the retina (Lo et al., 1991; Guillemot and Joyner, 1993; Por-
1989) was kindly provided by Dr. J. Rossant. All constructs in Fig. 3teus et al., 1994; Ahmad, 1995; Gordon et al., 1995; Jasoni
place fragments of the 5* distal Mash1 region upstream of the hsp68
and Reh, 1996). In the CNS, Mash1 is localized to domains basal promoter in hsp68lacZpA. For assembly of transgenes 11 and
within the ventral telencephalon, the diencephalon, the 14, the speci®ed restriction enzymes were used. Transgene 12 was
dorsal mesencephalon, metencephalon, myelencephalon, made from No. 5 by replacing a KpnI/ClaI fragment with a KpnI/
and dorsal spinal neural tube. Much lower levels of Mash1 ClaI fragment from hsp68lacZpA which replaces the Mash1 proximal
0.9-kb sequence with the hsp68 basal promoter but retains the 3*mRNA expression have also been observed in dorsal telen-
UTR from Mash1. Transgene 13 is similar to No. 11 with the additioncephalon and ventral mesencephalon (Guillemot and
of the Mash1 3* sequence in the opposite orientation. Mash1 frag-Joyner, 1993). In the PNS, expression is observed in sympa-
ments for transgenes 15±33 were generated by PCR with appropriatethetic, parasympathetic, and enteric neural precursors but
primers from within the 1158-bp enhancer sequence. Transgenes gen-not in neural precursors of the sensory, cranial or dorsal
erated by PCR were sequenced across the PCR regions.root ganglia. In vitro studies using neural crest and olfactory
Further details on generation of constructs will be provided on
epithelial cell cultures suggest that Mash1 functions in request. Transgene fragments were isolated from vector sequences
early differentiating neuronal precursors within these lin- and prepared for injection as previously described (Verma-Kurvari
eages (Gordon et al., 1995; Lo and Anderson, 1995; Sommer et al., 1996).
et al., 1995). An essential role for Mash1 in neurogenesis
was demonstrated by a targeted disruption of the Mash1
Generation and Analysis of Transgenic Micegene which results in the loss of most peripheral autonomic
and olfactory epithelial neurons (Guillemot et al., 1993). Transgenic embryos were generated and screened as described
Given the essential role of Mash1, and the restricted spa- previously using eggs from B6D2F1 crosses (Verma-Kurvari et al.,
tial and temporal expression pattern during neurogenesis, 1996). Data for transgene 1 are from established transgenic mice
it is likely that the precise regulation of Mash1 expression lines. All other transgenes were analyzed as founder embryos. Em-
is critical for proper neural development. The identi®cation bryos were harvested at embryonic day E11.5 and ®xed in 4% form-
aldehyde for 30 min at room temperature for b-gal staining as de-of cis-acting elements required for Mash1 expression pro-
scribed (Verma-Kurvari et al., 1996). Embryos positive for b-galvides a powerful approach to identify signaling pathways
activity were post®xed, cleared in methyl salicylate, and photo-that control early stages of nervous system development.
graphed under bright ®eld. To identify expression in speci®c re-In a previous report, we demonstrated that cis-regulatory
gions, embryos were rehydrated, embedded in agarose, and vibra-elements responsible for Mash1 expression in the CNS re-
tome sectioned at 300 mm. Transgenic embryos were identi®ed by
side within 10.5-kb 5* and 2.7-kb 3* ¯anking the coding dot blot analysis of the yolk sac DNA using a 32P-labeled lacZ probe
sequence and that the elements required for expression in (Verma-Kurvari et al., 1996).
the PNS, olfactory epithelium, and retina are likely in dis-
tinct regions (Verma-Kurvari et al., 1996). Here, we delin-
eate an enhancer within the Mash1 5* ¯anking region. This RESULTS
enhancer contains both positive and negative cis-acting ele-
ments which combine to drive Mash1-speci®c expression Localization of a CNS-Speci®c Enhancer
in multiple domains within the developing CNS. The data
suggest that this enhancer may also contain elements for Sequences driving Mash1 expression in speci®c CNS re-
gions reside within 10.5 kb upstream and 2.7 kb down-expression in the PNS and the olfactory epithelium.
stream of the Mash1 coding region (Fig. 2A and Verma-
Kurvari et al., 1996). In this study, smaller fragments from
the 5* ¯anking sequence were tested in transgenic mice
to further characterize the cis-acting regulatory elementsMATERIALS AND METHODS
controlling Mash1 expression in the CNS. Each transgene
was injected into fertilized mouse eggs generating trans-
Transgene Construction genic embryos. LacZ expression was analyzed in embryos
at E11.5, a stage at which high levels of Mash1 expression
Genomic Mash1 fragments tested in this study were isolated are detected in many regions of the CNS and the PNS (Lo
from a mouse pWE15 cosmid library from Stratagene. The assembly et al., 1991; Guillemot and Joyner, 1993). The 5* fragments
of transgenes 1 and 3 have been described previously (Verma-Kur- were tested for enhancer activity in combination with a
vari et al., 1996, see J1B and J1D). They contain 10.5-kb (No. 1)
lacZ reporter construct driven by the Mash1 basal promoterand 2.8-kb (No. 3) 5* and 2.7-kb 3 * of the Mash1 coding region.
and containing Mash1 3 * sequence (Fig. 1, transgene 2). TheThe lacZ reporter construct driven by the Mash1 basal promoter,
basic Mash1/lacZ reporter by itself is not suf®cient to drivetransgene 2, is a SphI fragment of 3. It contains 0.9-kb 5* sequence
lacZ expression in the CNS (Fig. 1, transgene 2). A singleincluding 315 bp upstream of the transcription start site and 575
bp of the untranslated region, and 2.7 kb on the 3 * end including 3.3-kb SacI fragment, located more than 5 kb 5* of the
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FIG. 1. Localization of an enhancer 5* of the Mash1 coding sequence. CNS expression of Mash1/lacZ reporter transgenes in E11.5
transgenic embryos. Transgenes 1±10 contain the lacZ coding sequence ¯anked by Mash1 sequences on the 5* and 3* ends. Speci®cally,
the 5* sequence contains 315 bp upstream of the transcription start site and the entire untranslated region (575 bp). The 3 * sequence
contains 2.7-kb Mash1 ¯anking sequence including the 3* untranslated region and intron found there. Transgenes 11±13 use a lacZ driven
by the hsp68 basal promoter. The poly(A) adenylation signal in Nos. 11 and 13 is contributed by SV40 and in No. 12 by Mash1 sequences.
All embryos were analyzed for lacZ expression as founder embryos except for transgene 1 embryos which come from established lines.
Data are presented as the number of independent transgenic embryos expressing the transgene in the Mash1-speci®c CNS pattern (CNS
expression) per the number of transgenic embryos identi®ed by DNA analysis (TgM). Lines indicate the Mash1 genomic sequence and
the arrows indicate the orientation of the fragments. The location of the transcription start site (bent arrow) and the translation start
(ATG) are shown in transgene 1. The hatched box indicates the location of the 5* enhancer. (a) CNS expression includes the ventral
telencephalon, thalamic and hypothalamic regions of the diencephalon, dorsal mesencephalon, metencephalon, myelencephalon, and the
dorsal spinal neural tube (see Fig. 2B for example). (b) 1 of 13 (transgene 8) and 1 of 12 (transgene 10) embryos had low-level expression
in diencephalon. (c) Expression in the ventral telencephalon, the thalamic region of the diencephalon, and the metencephalon is lacking
in these embryos. B, BamHI; H, HpaI; N, NcoI; P, Pst I; S, SacI; SP, SphI; X, XbaI.
Mash1 coding region, when coupled with the Mash1 basal 5* of the Mash1 coding region. This does not exclude the
possibility that additional regulatory elements are presentreporter consistently directs lacZ expression to Mash1-ex-
pressing regions in the CNS (Fig. 1, transgene 5; Fig. 2B). elsewhere in the 3.3-kb sequence.
Fragments outside this 3.3-kb sequence fail to drive lacZ
expression in these regions (Fig. 1; transgenes 3, 4, and 7).
A Role for Mash1 3 * Sequence for Ef®cientThe 3.3-kb fragment functions in a Mash1-speci®c manner
Expression in Multiple CNS Regionsin the CNS irrespective of its orientation (Fig. 1; transgene
6), although in the orientation opposite to wild type, it func- The distal 5* 3.3-kb SacI fragment was tested for enhancer
activity in combination with a heterologous promoter totions less ef®ciently. The 3.3-kb SacI fragment can be re-
placed, although much less ef®ciently, by a central 1.6-kb test whether it could function ef®ciently without the basal
Mash1 promoter or 3 * sequences. We used the reporterHpaI/BamHI fragment (Fig. 1, transgene 9). Other sequences
outside of the 1.6 kb but within the 3.3 kb are unable to hsp68lacZpA (Kothary et al., 1989) which contains the
hsp68 basal promoter upstream of a lacZ-coding region fol-ef®ciently drive expression of the transgene in the appro-
priate CNS regions (Fig. 1, transgenes 8 and 10). Taken to- lowed by an SV40 polyadenylation signal cassette. The 3.3-
kb SacI fragment is suf®cient to direct lacZ expression fromgether these results suggest a transcriptional enhancer suf-
®cient for driving Mash1 expression in the CNS is con- the heterologous promoter but only in a subset of Mash1-
expressing regions in the CNS (Fig. 1, transgene 11; Fig. 2C).tained within a 1.6-kb sequence located approximately 7 kb
Copyright q 1998 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8873 / 6x3c$$$102 04-02-98 09:23:52 dba
109Regulation of Mash1
FIG. 2. b-Gal staining in Mash1/lacZ transgenic embryos. (A±E) Representative transgenic embryos at E11.5 stained for b-gal activity
as whole mounts, cleared in methyl salicylate, and photographed under bright®eld illumination. The transgene number is as indicated in
each panel and refers to transgenes diagrammed in Fig. 1 and shown schematically in F. hy, hypothalamic region of diencephalon; mes,
mesencephalon; met, metencephalon; my, myelencephalon; nt, dorsal spinal neural tube; t, thalamic region of the diencephalon; vt, ventral
telencephalon. Arrowheads in D indicate the three regions of CNS requiring the Mash1 3 * sequence for expression. In F, the blue box is
the lacZ coding region ¯anked by Mash1 sequences (black lines). The red box is the hsp68lacZ reporter with the black box indicating the
SV40 3 * cassette.
Consistent expression is observed only in the hypothalamic The loss of lacZ expression in speci®c CNS regions when
the enhancer is combined with a heterologous promoterregion of the diencephalon, dorsal mesencephalon, myelen-
cephalon, and the dorsal spinal neural tube, but not in other suggests that elements within the 0.9-kb 5* or 2.7-kb 3*
¯anking the Mash1 coding region may contribute to expres-Mash1-speci®c CNS regions including the ventral telen-
cephalon, thalamic region of the diencephalon, and the met- sion in multiple regions of the CNS. However, these Mash1
regions are not suf®cient to drive reporter expression onencephalon (compare Figs. 2B and 2C).
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their own (Fig. 1, transgene 2). To determine if the 3* se- to further de®ne the sequence suf®cient to regulate Mash1-
speci®c CNS expression. The effect of each deletion inquence is responsible for the apparent regulatory activity,
the SV40 polyadenylation signal cassette in the Mash1-en- transgenic embryos was evaluated by the percentage of
transgenic embryos expressing lacZ in the CNS, the loss ofhancer/hsp68lacZpA transgene (No. 11) was replaced with
the 2.7-kb Mash1 3 * sequence. In embryos carrying this expression in speci®c CNS regions, and the overall expres-
sion levels when compared to the full-length 1158-bp en-reporter (No. 12), LacZ expression is recovered in all Mash1-
speci®c CNS regions including the ventral telencephalon, hancer (transgene 14). Each deletion was tested on the
hsp68lacZpA heterologous reporter and assayed in trans-thalamic region of the diencephalon, and the metencepha-
lon (Fig. 1, transgene 12; Fig. 2D, arrowheads). Thus, the 3* genic embryos at E11.5.
Deletions of the 1158-bp sequence either on the 5* and/2.7-kb sequence, which includes 3 * untranslated sequence,
appears to cooperate with the distal enhancer to yield de- or the 3* end were tested to identify boundaries of the en-
hancer. Deletions of 177 bp from the 5* end or 118 bp fromtectable levels of transgene expression in these three
Mash1-expressing CNS domains. the 3 * end of the enhancer were tolerated and expression
was detected in the CNS regions seen with the full-lengthTwo possibilities exist for the function of the 3 * sequence
in regulating Mash1 expression in the CNS. First, the 2.7- enhancer (Fig. 3, transgenes 15 and 19; Figs. 4B and 4C).
However, when these sequences were deleted in combina-kb sequence may contain enhancer elements that direct
expression only when combined with additional elements tion, there was a signi®cant loss of enhancer activity (com-
pare Fig. 3, transgenes 15 and 19 with 22; Figs. 4B and 4Cin the 5* enhancer. Alternatively, since the 3 * Mash1 se-
quence also contributes the 3 * UTR, it is possible that post- with 4D). These results suggest that activator elements are
contained within nucleotides 1±177 and 1040±1158, andtranscriptional regulation occurs, and transcripts made with
the Mash1 3 * sequences are translated more ef®ciently, or when both elements are deleted only inef®cient expression
of the transgene is maintained by elements which are pres-are more stable, than those containing the SV40 sequence.
To help distinguish between these possibilities, we tested ent within the internal nucleotides 178±1039. Additional
deletions from either the 5* and/or 3 * ends resulted in sig-the 3 * sequence but in the opposite orientation (transgene
13). Thus, this transgene uses the poly(A) addition cassette ni®cant loss of enhancer activity (Fig. 3, transgenes 16±26).
This 5* and 3 * enhancer deletion analysis suggests that therefrom SV40 instead of from Mash1, but would still allow
enhancer elements within the 2.7-kb 3 * sequence to be re- are multiple elements within the 1158-bp sequence re-
quired for enhancer activity. Further characterization ofvealed. In embryos containing this transgene, expression
was detected only in the partial CNS pattern and lacked these elements is provided below.
expression in the ventral telencephalon, thalamic region of
the diencephalon, and the myelencephalon (Fig. 1, trans-
Deletion of a Putative Negative Regulatory Regiongene 13; Fig. 2E). These data suggest that the 3 * ¯anking
Reveals Additional Properties of the Enhancersequence does not contain enhancer elements for Mash1
expression, but rather the 3 * UTR within this sequence may The presence of a negative element(s) is suggested with
the deletion of 118 bp from the 3* end of the 1158-bp en-harbor elements responsible for posttranscriptional regula-
tion in speci®c regions of the CNS. hancer (transgene 15). This deletion results in an overall
increase in expression from the transgene in Mash1-speci®c
regions (compare Figs. 4A and 4B). Strikingly, in 4 of the 7
Multiple Regulatory Elements Are Contained embryos, b-gal activity was detected in the complete CNS
within the Distal 5* Enhancer pattern, the pattern seen previously only when the Mash1
3 * ¯anking sequence was present in the transgene. Thus,We observed that as the size of the enhancer decreased,
the ef®ciency of obtaining transgenic embryos with high deletion of 118 bp on the 3 * end of the enhancer results
in expression not only in the hypothalamic region of thelevels of expression also decreased. We also observed that
if we tested the enhancer with the hsp68lacZpA reporter, diencephalon, dorsal mesencephalon, myelencephalon, and
the dorsal spinal neural tube, but also in the ventral telen-we consistently obtained a high level of expression in a
subset of CNS regions as outlined above. The smallest cephalon, thalamic region of the diencephalon, and the met-
encephalon (Fig. 4B, arrowheads). These data suggest that aMash1 enhancer fragment that functions ef®ciently in this
transgenic assay is a 1158-bp HpaI/Pst I fragment found negative regulatory element(s) is contained within the 118-
bp sequence between nucleotides 1040 and 1158 of the en-within the 3.3-kb enhancer (hatched box in Fig. 1, transgene
1). This 1158-bp enhancer is suf®cient to drive Mash1-spe- hancer since when deleted, both an increased overall expres-
sion level and expression in additional Mash1-speci®c re-ci®c expression to the CNS in 5 of 6 embryos assayed (Fig.
3, transgene 14; Fig. 4A). Although sequence analysis of the gions is observed. In addition, these data demonstrate the
presence of positive elements for the complete CNS pattern1158-bp enhancer revealed sequences resembling transcrip-
tion factor consensus binding sites for homeodomain fac- within nucleotides 1±1039 of the enhancer that function
without additional Mash1 3 * sequence.tors and bHLH factors, it was uninformative in revealing
any speci®c regulatory components. Surprisingly, in several transgenic embryos containing
nucleotides 1±1039, expression was observed in regionsA series of deletions of this 1158-bp enhancer were tested
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FIG. 3. Multiple regulatory elements within the 5* enhancer. All transgenes test the indicated enhancer sequences in combination with
the hsp68lacZpA reporter in transgenic mice at E11.5. Data are presented as the total number of transgenic embryos identi®ed by DNA
analysis (TgM), and the number of embryos expressing lacZ within a subset of Mash1-speci®c regions in the CNS (partial CNS). Within
the CNS, lacZ expression is scored in the hypothalamic region of the diencephalon (hy), dorsal mesencephalon (dmes), and the myelencepha-
lon and/or the dorsal spinal neural tube (my/dnt). / indicates easily detectable, //0 indicates barely detectable and/or expression in a
low percentage of transgenic embryos, and 0 indicates lack of lacZ expression in that particular CNS region. Refer to Fig. 1 (hatched box)
for the location of the enhancer relative to the Mash1 coding region. (a) In multiple embryos with transgene 15, expression is also observed
in the ventral telencephalon, thalamic region of the diencephalon, the metencephalon, and in olfactory epithelium and enteric regions.
(b) In 1 of 5 embryos (transgene 19), and 1 of 3 embryos (transgene 31), expression is observed in the ventral telencephalon.
containing the sympathetic, enteric, and olfactory neuronal The sequence of the 118 bp containing the putative nega-
tive element contains a consensus binding site for the ZEB Znprecursors (Fig. 4B, arrows). Expression in these regions ac-
curately re¯ects the endogenous Mash1 expression pattern. ®nger transcription factor. In vitro studies have demonstrated
that ZEB binds to an extended E-box sequence (GCAGGTG)Expression in the sympathetic and enteric precursors was
previously detected in Mash1/lacZ transgenic embryos only within an enhancer of the immunoglobulin heavy chain gene
where it appears to act as a repressor of transcription (Genettawhen 36 kb of Mash1-¯anking sequence was included
(Verma-Kurvari et al., 1996). Expression of Mash1/lacZ et al., 1994). To test directly whether this sequence was re-
sponsible for the repressor activity observed in the 118-bptransgenes in olfactory epithelium has never been detected
even with the largest transgenic constructs (Verma-Kurvari deletion (transgene 15), we mutated the ZEB consensus bind-
ing site to (CTGTTCA), which also mutates the overlappinget al., 1996). While the expression of lacZ in the sympa-
thetic precursors was detected in only one transgenic em- E-box (CAGGTG), and tested its function in transgenic em-
bryos. Embryos expressing the mutated transgene showbryo containing the 118-bp deleted enhancer, expression in
the olfactory epithelium and enteric regions was observed higher levels of expression in general, but none give the com-
plete CNS/PNS Mash1 pattern as seen with the 118-bp dele-in several embryos (Fig. 4B and data not shown). Thus, dele-
tion of a putative negative element may be revealing posi- tion (Fig. 3, transgene 33; Fig. 4E). It appears that the ZEB/E-
box site contributes to the level of activity of the 1158-bptive elements for expression in the PNS and olfactory re-
gions, not previously detected, which colocalize with the enhancer but additional elements within the 118-bp region
may be required for full inhibitory activity.CNS elements.
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FIG. 4. b-Gal staining in Mash1/hsp68lacZpA transgenic embryos. (A±H) Representative transgenic embryos at E11.5 stained for b-gal
activity as whole mounts, cleared in methyl salicylate, and photographed under bright®eld illumination. The transgene number is as
indicated in each panel and refers to transgenes diagrammed in Fig. 3. Expression in the ventral telencephalon, thalamic region of the
diencephalon, and the metencephalon is indicated by arrowheads in B. LacZ expression in Mash1-speci®c regions of the PNS and the
olfactory epithelium is indicated by arrows in B and H. Ectopic expression (∗) in ventral neural tube is commonly observed in embryos
injected with Mash1/hsp68lacZpA constructs.
Identi®cation of Region-Speci®c Elements expression in the hypothalamic region of the diencephalon
and very minimal expression in the dorsal mesencephalonwithin the Enhancer
(Figs. 3, 4F). A transgene deleting 177 bp on the 5* end does
An interesting question is whether within the enhancer, not effect expression in these regions (Fig. 3, transgene 19;
different elements function to drive transcription in speci®c compare Fig. 4C with 4F). Together, these data suggest ele-
regions within the Mash1-speci®c expression domains. For ments important for expression in the hypothalamic region
example, is there an element that is required for expression of the diencephalon and possibly the dorsal mesencephalon
in the hypothalamic region of the diencephalon versus the are contained within nucleotides 178±397.
dorsal mesencephalon or dorsal spinal neural tube? The in- To examine the function of this sequence in more detail,
ef®cient expression from the enhancer deletions, visualized we tested whether it was necessary and/or suf®cient for en-
as the low percentage of transgenic embryos expressing, hancer function. A deletion between nucleotides 246±397
make this type of conclusion dif®cult in some cases such severely compromises the ability of the enhancer to function
as in transgenes 16 and 23 where there is only a single not only in the diencephalon, but also in the other CNS
expressing embryo out of 6 and 10 transgenic embryos, re- regions (Fig. 3, transgene 29). Two of the three lacZ-express-
spectively. However, for transgene 20 which deletes 397 bp ing embryos with this deletion had extremely high ectopic
expression throughout the nonneural tissues. Vibratome sec-from the 5* end, there are 5 expressing embryos all lacking
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FIG. 5. Summary diagram of sequences regulating Mash1 expression. 13 kb from the Mash1 locus is shown. The open boxes represent
the Mash1-transcribed region, ATG is the start codon, and the asterisk is the stop codon. The hatched box represents the 1158-bp 5*
Mash1 enhancer. Regions functioning in regulating Mash1 expression are indicated as A±E. (A) nucleotides 178±650, containing positive
elements for expression in the dorsal mesencephalon, myelencephalon, and dorsal spinal neural tube; (B) nucleotides 178±447, containing
positive elements for diencephalon expression. Deletions within regions A and B dramatically reduce the activity of the enhancer. C
contains negative elements, some of which may be attributed to a ZEB/E-box site within the sequence. D is the 315-bp sequence that
acts as a basal promoter in transgenes 1±10. Sequence in E contains regulatory information, possibly at a posttranscriptional level, for
ef®cient expression of the transgene in the ventral telencephalon, the thalamic region of the diencephalon, and the metencephalon, when
combined with the 5* enhancer.
tions of these embryos revealed some expression in the hypo- of this sequence are present in tandem, Mash1-speci®c ex-
pression was detected at a low frequency in the dorsal mes-thalamic region of the diencephalon but no expression in
other Mash1-speci®c CNS regions. These results combined encephalon and the dorsal spinal neural tube (Fig. 3,
transgene 28; Fig. 4H). Surprisingly, in one of these embryos,with the 5* deletions suggest that nucleotides 246±397 har-
bor essential positive elements for ef®cient Mash1-speci®c expression was also detected in the olfactory epithelium
and the sympathetic region (Fig. 4H, arrows). We concludeCNS expression. We next addressed the question of whether
this sequence is suf®cient to drive expression to any of the that sequence within nucleotides 398±650 is essential for
full enhancer function, and that it contains an element(s)Mash1-speci®c CNS regions. Data from transgene 17, which
tests nucleotides 1±650, suggest that as a single copy this able to drive transcription speci®cally to the dorsal mesen-
cephalon and dorsal spinal neural tube.region is not suf®cient to drive expression. However, since
regulatory elements often do not function ef®ciently in these Two additional deletions within the enhancer were tested
for their ability to disrupt enhancer function. Deletion oftypes of assays as a single copy, we tested the sequence from
nucleotides 178 to 447 as a tandem array of 3 copies for nucleotides 652±795 or 856±987 within the context of the
1158-bp enhancer did not have dramatic consequences forenhancer activity. Consistent strong expression from this
transgene was observed in the dorsal mesencephalon with enhancer function (Fig. 3, transgenes 31 and 32).
variable expression in the hypothalamic region of the dien-
cephalon and in the myelencephalon/dorsal spinal neural
tube (Fig. 3, transgene 27; Fig. 4G). Expression was also con- DISCUSSION
sistently observed in regions around the ventral telencepha-
lon and the olfactory epithelium. However, in both cases, Little is known about the factors that control the expres-
sion of essential neural regulatory genes of the bHLH familythe expression does not re¯ect the correct Mash1 pattern.
These data demonstrate the presence of a regulatory ele- of transcription factors. Expression of these genes is tightly
regulated both spatially and temporally in the developingment(s) within nucleotides 178±447 suf®cient to drive tran-
scription speci®cally in a subset of the Mash1 CNS pattern nervous system, suggesting that this regulation is important
for proper development to occur. Previous studies of Mash1most strongly in the dorsal mesencephalon.
A second region was identi®ed that also appears to have regulation suggested regulatory elements governing different
domains of expression are distributed broadly in greater thanan essential role in the function of the 1158-bp enhancer.
A deletion of nucleotides 448±595 within the context of 36 kb ¯anking the Mash1 coding region. Here we demon-
strate the complexity in the regulation of Mash1 at multiplethe enhancer completely disrupts enhancer activity (Fig. 3,
transgene 30). Disruption of enhancer function with inter- levels. We localize a 1158-bp CNS enhancer to a region7 kb
5* of the coding sequence. This enhancer contains multiplenal deletions such as this suggests that an essential element
lies within the deletion or that spacing between remaining positive and negative elements that appear to act together to
yield the Mash1 expression pattern in speci®c regions of theregulatory elements is disrupted. To determine whether
this region is suf®cient to drive Mash1-speci®c expression, developing CNS (see summary diagram, Fig. 5).
The clustering of positive and negative cis-acting regula-one and two copies of the sequence from 398 to 650 were
tested. One copy of this sequence is not suf®cient to drive tory elements within a restricted region of DNA demon-
strated here for Mash1 has been described previously forexpression (Fig. 3, transgene 25). However, when two copies
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many genes in sea urchin, Drosophila, and mammals (Kruse level of sequence and function. Therefore, it is of interest
to consider whether there is also conservation of regulatoryet al., 1993; Li et al., 1996; Morrison et al., 1996; Song et
al., 1996). In genes that are regulated by multiple positive mechanisms. Genetic and biochemical studies in Drosoph-
ila have identi®ed many candidate genes which regulateelements, such as HOXD4, often a single regulatory ele-
ment by itself is not suf®cient for expression; however, dele- achaete±scute expression (Skeath et al., 1992; Ramain et
al., 1993; Ohsako et al., 1994; van Doren et al., 1994; Jimi-tion of the same element is enough to abolish expression
(Morrison et al., 1996). This appears to be the case for ele- nez et al., 1995; Cubadda et al., 1997). The two homeodo-
main proteins, ARA and CAUP, upregulate transcription ofments within the 1158-bp Mash1 enhancer as well. Only
when the sequences are tested as multimers is speci®c ex- achaete and scute genes and ARA has been shown to inter-
act directly with the sequences in the achaete±scute en-pression revealed.
Genes that show complex expression patterns in multiple hancer (GoÂmez-Skarmeta et al., 1996). Sequence analysis of
the 1158-bp Mash1 enhancer indicates the presence of sev-cell types often have separate elements for expression in the
different regions (Small et al., 1992; Kruse et al., 1993; Logan eral A/T-rich regions which include multiple consensus
binding sites for homeodomain proteins. The speci®c bind-et al., 1993; Zimmerman et al., 1994; Li et al., 1996). Previous
work testing 36 kb of Mash1-¯anking sequence suggested ing site for ARA, as identi®ed in the achaete±scute en-
hancer, however, does not have a match within the Mash1that elements for Mash1 expression in the PNS, or the olfac-
tory epithelium and the retina, are distinct from each other enhancer sequence and the binding site for CAUP has not
been characterized. Mammalian homologs of ara and caupand from those functioning in CNS expression (Verma-Kur-
vari et al., 1996). Here we have identi®ed an enhancer that have been identi®ed (P. Gruss, personal communication).
Whether these mammalian homologs regulate Mash1 ex-functions ef®ciently for CNS expression. However, data from
multiple transgenes suggest that positive elements for ex- pression awaits characterization of their expression pattern,
the ability to bind to Mash1 enhancer sequences, and thepression in the PNS and olfactory epithelium colocalize with
this CNS enhancer. The transgene containing nucleotides 1± effect of mutating their binding sites.
1039 (transgene 15) functioned reproducibly to drive expres-
sion in the PNS and olfactory epithelium (Fig. 4B). In addi-
tion, in one embryo, a multimer of nucleotides 397±650 ACKNOWLEDGMENTS
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